Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
Quick Stats
May 14, 202651.3
AI Score
HOLD0.44
Volume Ratio
May 12, 2026
Next Earnings
10
+ve Days (30d)
19
-ve Days (30d)
ARVN Stock Summary
Last updated May 14, 2026
ARVN is currently trading at $9.46, positioned below its 200-day moving average of $10.56, suggesting bearish momentum. The stock has a 52-week range of $5.9 to $14.51.
Technical Analysis: The 50-day moving average stands at $11.0, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 35.484, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.166, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates ARVN at 51.3/100 with a HOLD recommendation.
ARVN (Arvinas, Inc) Indicators
Last updated May 14, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 35.484 |
| CMF (20) | -0.166 |
| ROC (10) | -4.242 |
| ADX (14) | 15.532 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.354 |
| AROONOSC (14) | -50.0 |
| WILLAMS %R (14) | -80.672 |
| MFI (14) | 36.999 |
ARVN Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
ARVN Price vs Max Options Open Interest
ARVN Max Change In Options Open Interest
ARVN Options - Sort by Max open Interest (near term)
14th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ARVN Daily Out of Money Options - Sort by Max open Interest (near term)
14th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ARVN Daily In the Money Options - Sort by Max open Interest (near term)
14th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ARVN Most Active Options by Volume(near term)
14th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Arvinas, Inc is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
ARVN Moving Averages Analysis
ARVN (Arvinas, Inc) Simple Moving Averages
Moving Averages are last updated May 14, 2026
| Days | MA |
|---|---|
| 10 | 10.1 |
| 20 | 10.26 |
| 30 | 10.51 |
| 50 | 11.0 |
| 100 | 11.78 |
| 200 | 10.56 |
ARVN Fundamental Analysis
| P/E (Forward) | 17.8571 |
| P/E (Trailing) | -- |
| Market Cap ($) | 617.4 million |
| Earnings/Share ($) | -3.18 |
| Net Proft Margin (%) | -2.4754 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -3.4924 |
| EPS Estimate Next Year ($) | -3.4583 |
| WallStreet Target Price ($) | 15.0625 |
| Most Recent Quarter |